Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions.
| Autor: | PAN, EVA Y., SOBIERAJ, DIANA M. |
|---|---|
| Zdroj: | Connecticut Medicine; Feb2016, Vol. 80 Issue 2, p105-111, 7p, 3 Charts |
| Abstrakt: | The article focuses on prescribing target specific oral anticoagulants (TSOACs) including dabigatran, rivaroxaban, and apixaban for renal dysfunction in U.S. It discusses the frequent use in outpatient conditions, risk factor of bleeding linked to dabigatran, and renal elimination for target specific oral anticoagulants. |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|